Printer-friendly versionPDF változat

Elderly patients have a high risk of complications after stroke, such as infections or fever. This study aims to assess whether preventive treatment in the first four days of hospitalisation with ceftriaxone, paracetamol, and/or metoclopramide prevents the most common complications and reduce the risk of death or long-term disability compared to standard care alone.

Disease: Stroke

Study phase: III

ECRIN support role: Monitoring

Funding application support

Study/trial status: Recruitment/follow-up

Actual trial start date: 01/03/2016

Expected patient number: 3800 patients

Sponsor: Universitair Medisch Centrum Utrecht

Sponsor type: Academic

Principal investigator (PI): Bart van der Worp

Current participating countries: Estonia, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, United Kingdom